A Half-Log Increase in BCR-ABL RNA Predicts a Higher Risk of Relapse in Patients with Chronic Myeloid Leukemia with an Imatinib-Induced Complete Cytogenetic Response

Richard D. Press, Michael W. Deininger, Rui Yang et al.|Clinical Cancer Research|2007

Cited by 123